Cannabidiol: From an Inactive Cannabinoid to a Drug with Wide Spectrum of Action

By | Alzheimer's Disease, Arthritis, Cancer, CBD, Diabetes, Nausea, Research Articles

CBD Health Benefits for Parkinson's, Diabetes, and More

The years 2003 – 2008 showed a remarkable increase in publications on cannabidiol mainly stimulated by the discovery of its anti-inflammatory, anti-oxidative and neuroprotective effects. These studies have suggested a wide range of possible therapeutic effects of cannabidiol on several conditions, including Parkinson’s disease, Alzheimer’s disease, cerebral ischemia, diabetes, rheumatoid arthritis, other inflammatory diseases, nausea and cancer. Read More

CBD & Chemotherapy Induced Neuropathy

By | Cancer, CBD, Neuropathy, Research Articles

CBD for Chemotherapy Induced Neuropathy | CBD and Chemotherapy

Taxol is a common chemotherapy agent that is a mitotic inhibitor. It is used to treat patients with lung, ovarian, breast, head & neck cancer and advanced forms of Kaposi’s sarcoma. One of the painful side effects of this agent is neuropathy, a side effect that can limit the effective use of the drug. This article shows promise in using CBD to help prevent the neuropathy caused by Taxol. Read More

Brain Tumors Regressing — Thanks to Cannabis?

By | Brain Health, Cancer, Research Articles

Cannabis for Brain Tumors | Effect of Cannabis on Gliomas

Cannabis for Brain Tumors: Two case reports in the journal Children’s Nervous System by Mansoor Foroughi and colleagues at BC Children’s Hospital in Vancouver discuss the “possible role of Cannabis inhalation” in the spontaneous regression of brain tumors (pilocytic astrocytomas). The cases involve a girl who underwent surgery at age 11 and a girl who underwent surgery at 13. In each case a remnant of the tumor could not be removed. Read More

SCC Hears McAllister On Cannabis Cancer Research

By | Cancer, CBD, Research Articles

SCC Hears McAllister On Cannabis Cancer ResearchSean McAllister, PhD, who has been studying the anti-cancer effects of cannabinoids in the laboratory (on a grant from NIH and with a license from the DEA). The occasion was the winter meeting of the Society of Cannabis Clinicians.”That’s a very good question,” McAllister would say…and provide the answer, and tie it back into his main thread. Read More